GB8513358D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB8513358D0
GB8513358D0 GB858513358A GB8513358A GB8513358D0 GB 8513358 D0 GB8513358 D0 GB 8513358D0 GB 858513358 A GB858513358 A GB 858513358A GB 8513358 A GB8513358 A GB 8513358A GB 8513358 D0 GB8513358 D0 GB 8513358D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858513358A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB858513358A priority Critical patent/GB8513358D0/en
Publication of GB8513358D0 publication Critical patent/GB8513358D0/en
Priority to US06/862,817 priority patent/US4929444A/en
Priority to HU862239A priority patent/HU200695B/en
Priority to ES555353A priority patent/ES8800601A1/en
Priority to GR861366A priority patent/GR861366B/en
Priority to JP61122049A priority patent/JPS6226233A/en
Priority to CA000510096A priority patent/CA1297008C/en
Priority to IT48065/86A priority patent/IT1191926B/en
Priority to IT48064/86A priority patent/IT1191925B/en
Priority to HU862234A priority patent/HU195733B/en
Priority to LU86445A priority patent/LU86445A1/en
Priority to SE8602405A priority patent/SE462016B/en
Priority to GR861365A priority patent/GR861365B/en
Priority to FR8607552A priority patent/FR2583984B1/en
Priority to CH2126/86A priority patent/CH665356A5/en
Priority to NO862095A priority patent/NO171344C/en
Priority to IL78937A priority patent/IL78937A/en
Priority to DE19863617753 priority patent/DE3617753A1/en
Priority to ES555352A priority patent/ES8706443A1/en
Priority to DK246786A priority patent/DK163173C/en
Priority to FR8607553A priority patent/FR2593393B1/en
Priority to CA000510097A priority patent/CA1300008C/en
Priority to ZA863955A priority patent/ZA863955B/en
Priority to AU57965/86A priority patent/AU569429B2/en
Priority to BE0/216712A priority patent/BE904831A/en
Priority to GB08612781A priority patent/GB2176703B/en
Priority to DE19863617752 priority patent/DE3617752A1/en
Priority to GB8612780A priority patent/GB2176702B/en
Priority to FI862227A priority patent/FI85335C/en
Priority to BE0/216711A priority patent/BE904830A/en
Priority to JP61122050A priority patent/JPS6226234A/en
Priority to NL8601355A priority patent/NL8601355A/en
Priority to NO862096A priority patent/NO171345C/en
Priority to ZA863956A priority patent/ZA863956B/en
Priority to NZ216306A priority patent/NZ216306A/en
Priority to FI862226A priority patent/FI85334C/en
Priority to PT82646A priority patent/PT82646B/en
Priority to AT0141186A priority patent/AT391812B/en
Priority to IL78938A priority patent/IL78938A/en
Priority to PT82647A priority patent/PT82647B/en
Priority to DK246886A priority patent/DK163174C/en
Priority to CH2127/86A priority patent/CH664495A5/en
Priority to SE8602404A priority patent/SE462893B/en
Priority to NL8601354A priority patent/NL8601354A/en
Priority to NZ216307A priority patent/NZ216307A/en
Priority to AU57964/86A priority patent/AU567236B2/en
Priority to LU86444A priority patent/LU86444A1/en
Priority to ES557374A priority patent/ES8802439A1/en
Priority to US07/226,422 priority patent/US4968617A/en
Priority to US07/527,634 priority patent/US5112609A/en
Priority to JP5230427A priority patent/JPH0759517B2/en
Pending legal-status Critical Current

Links

GB858513358A 1985-05-28 1985-05-28 Formulation Pending GB8513358D0 (en)

Priority Applications (51)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
US06/862,817 US4929444A (en) 1985-05-28 1986-05-13 Low pH pharmaceutical formulation containing t-PA
HU862239A HU200695B (en) 1985-05-28 1986-05-27 Process for producing stable pharmaceutical compositions comprising tissural plasminogene activator
ES555353A ES8800601A1 (en) 1985-05-28 1986-05-27 Solid hydrochloride salt of t-PA
GR861366A GR861366B (en) 1985-05-28 1986-05-27 Novel formulation
JP61122049A JPS6226233A (en) 1985-05-28 1986-05-27 Medicine containing tissue plasminogen activator
CA000510096A CA1297008C (en) 1985-05-28 1986-05-27 Aqueous parenteral solution of tissue-plasminogen activator
IT48065/86A IT1191926B (en) 1985-05-28 1986-05-27 LYOPHILIZED PHARMACEUTICAL FORMULATION OF TISSUE PLASMINOGEN ACTIVATOR AND RELATED PREPARATION PROCEDURE
IT48064/86A IT1191925B (en) 1985-05-28 1986-05-27 PARENTERAL WATER SOLUTION OF TISSUE PLASMINOGEN ACTIVATOR AND PREPARATION PROCEDURE
HU862234A HU195733B (en) 1985-05-28 1986-05-27 Process for preparing a pharmaceutical composition containing tissue plasminogen activator
LU86445A LU86445A1 (en) 1985-05-28 1986-05-27 PLASMINOGEN TISSUE ACTIVATOR COMPOSITION
SE8602405A SE462016B (en) 1985-05-28 1986-05-27 PROCEDURE FOR ORGANIZING A LYOFILIZED PHARMACEUTICAL COMPOSITION WITH TISSUE PLASMINOGEN ACTIVATOR, T-PA
GR861365A GR861365B (en) 1985-05-28 1986-05-27 Novel formulation
FR8607552A FR2583984B1 (en) 1985-05-28 1986-05-27 LYOPHILIZED PHARMACEUTICAL FORMULATION OF PLASMINOGEN TISSUE ACTIVATOR, PROCESS FOR PREPARING SAME, CONTAINER CONTAINING SAME AND SALT OF PLASMINOGEN TISSUE ACTIVATOR
CH2126/86A CH665356A5 (en) 1985-05-28 1986-05-27 PHARMACEUTICAL FORMULATION.
NO862095A NO171344C (en) 1985-05-28 1986-05-27 PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING Tissue PLASMINOGEN ACTIVATOR
IL78937A IL78937A (en) 1985-05-28 1986-05-27 Pharmaceutical compositions containing tissue-plasminogen activator
DE19863617753 DE3617753A1 (en) 1985-05-28 1986-05-27 TISSUE PLASMINOGEN ACTIVATOR, THE PHARMACEUTICAL FORMULATIONS CONTAINING IT AND THEIR PRODUCTION AND USE IN HUMAN AND VETERINE MEDICINE
ES555352A ES8706443A1 (en) 1985-05-28 1986-05-27 Acidic formulations of t-PA
DK246786A DK163173C (en) 1985-05-28 1986-05-27 PROCEDURE FOR THE PREPARATION OF A LYOPHILIZED PHARMACEUTICAL PREPARATION OF TABLE PLASMINOGEN ACTIVATOR (T-PA)
FR8607553A FR2593393B1 (en) 1985-05-28 1986-05-27 AQUEOUS SOLUTION FOR PARENTERAL USE OF PLASMINOGEN TISSUE ACTIVATOR, PROCESS FOR PREPARING THE SAME AND CONTAINER CONTAINING THE SAME
CA000510097A CA1300008C (en) 1985-05-28 1986-05-27 Acid lyophilised pharmaceutical formulation of tissue plasminogen activator
ZA863955A ZA863955B (en) 1985-05-28 1986-05-27 Novelformulation
AU57965/86A AU569429B2 (en) 1985-05-28 1986-05-27 Aqueous acidic tissue plasminogen activator parenternal formulation
BE0/216712A BE904831A (en) 1985-05-28 1986-05-27 PLASMINOGEN TISSUE ACTIVATOR COMPOSITION.
GB08612781A GB2176703B (en) 1985-05-28 1986-05-27 Novel formulation
DE19863617752 DE3617752A1 (en) 1985-05-28 1986-05-27 TISSUE PLASMINOGEN ACTIVATOR, THE PHARMACEUTICAL FORMULATIONS CONTAINING THEM, THEIR PRODUCTION AND THEIR USE IN HUMAN AND VETERINE MEDICINE
GB8612780A GB2176702B (en) 1985-05-28 1986-05-27 Novel formulation.
FI862227A FI85335C (en) 1985-05-28 1986-05-27 Process for Preparation of Lyophilized Pharmaceutical Tissue Plasma Minogen Activator (t-PA) Composition
BE0/216711A BE904830A (en) 1985-05-28 1986-05-27 NEW COMPOSITION OF PLASMINOGEN TISSUE ACTIVATOR.
JP61122050A JPS6226234A (en) 1985-05-28 1986-05-27 Non-oral solution medicine
NL8601355A NL8601355A (en) 1985-05-28 1986-05-27 NEW COMPOSITION.
NO862096A NO171345C (en) 1985-05-28 1986-05-27 PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING Tissue PLASMINOGEN ACTIVATOR
ZA863956A ZA863956B (en) 1985-05-28 1986-05-27 Pharmaceutical formulations containing tissue plasminogen activator
NZ216306A NZ216306A (en) 1985-05-28 1986-05-27 Pharmaceutical compositions containing tissue plasminogen activator
FI862226A FI85334C (en) 1985-05-28 1986-05-27 Process for Preparation of an Aqueous Tissue Plasminogenic Tivator (t-PA) Containing Concentrated Parent Solution
PT82646A PT82646B (en) 1985-05-28 1986-05-27 Process for the preparation of lyophilized pharmaceutical compositions comprising a plasticizer activator of woven fabrics
AT0141186A AT391812B (en) 1985-05-28 1986-05-27 METHOD FOR PRODUCING A PARENTERAL T-PA SOLUTION
IL78938A IL78938A (en) 1985-05-28 1986-05-27 Pharmaceutical composition containing lyophilized tissue plasminogen activator and its preparation
PT82647A PT82647B (en) 1985-05-28 1986-05-27 PROCESS FOR THE PREPARATION OF AN AQUOSA PARENTERAL SOLUTION OF TISSUE PLASMINOGENEUM ACTIVATOR
DK246886A DK163174C (en) 1985-05-28 1986-05-27 VERY CONCENTRATED PARENTERAL SOLUTION OF TISSUE PLASMINOGEN ACTIVATES (T-PA) AND PROCEDURES FOR PREPARING THEM
CH2127/86A CH664495A5 (en) 1985-05-28 1986-05-27 PHARMACEUTICAL FORMULATION.
SE8602404A SE462893B (en) 1985-05-28 1986-05-27 Aqueous PARENTERAL SOLUTION OF TISSUE PLASMINOGEN ACTIVATOR AND SET FOR PREPARATION OF IT
NL8601354A NL8601354A (en) 1985-05-28 1986-05-27 NEW COMPOSITION.
NZ216307A NZ216307A (en) 1985-05-28 1986-05-27 Pharmaceutical compositions containing tissue plasminogen activator
AU57964/86A AU567236B2 (en) 1985-05-28 1986-05-27 Pharmaceutical formulation of tissue plasminogen activator
LU86444A LU86444A1 (en) 1985-05-28 1986-05-27 NEW COMPOSITION OF PLASMINOGEN TISSUE ACTIVATOR
ES557374A ES8802439A1 (en) 1985-05-28 1987-02-10 Solid hydrochloride salt of t-PA
US07/226,422 US4968617A (en) 1985-05-28 1988-07-29 Solid hydrochloride salt of t-PA
US07/527,634 US5112609A (en) 1985-05-28 1990-05-21 Acidic formulations of t-PA
JP5230427A JPH0759517B2 (en) 1985-05-28 1993-09-16 Pharmaceutical composition containing tissue plasminogen activator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation

Publications (1)

Publication Number Publication Date
GB8513358D0 true GB8513358D0 (en) 1985-07-03

Family

ID=10579735

Family Applications (1)

Application Number Title Priority Date Filing Date
GB858513358A Pending GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation

Country Status (3)

Country Link
JP (2) JPS6226234A (en)
GB (1) GB8513358D0 (en)
ZA (2) ZA863955B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
JPS62292729A (en) * 1986-06-12 1987-12-19 Toyobo Co Ltd Plasminogen activator pharmaceutical derived from human uterine tissue
EP0292009A1 (en) * 1987-05-22 1988-11-23 Zymogenetics, Inc. Fibrinolytic proteins
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8003402A (en) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw NEW PLASMINOGEN ACTIVATOR AND PHARMACEUTICAL PREPARATION WITH THROMBOLYTIC ACTION.
HU200615B (en) * 1982-05-05 1990-07-28 Genentech Inc Methods of preparing tissue plasiminogen activator derivative composition
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
JPS60181028A (en) * 1984-02-29 1985-09-14 Asahi Chem Ind Co Ltd Dissolution assisting method of tissue plasminogen activator
JPS60184026A (en) * 1984-03-01 1985-09-19 Asahi Chem Ind Co Ltd Method for promoting dissolution of tissue plasminogen activator

Also Published As

Publication number Publication date
ZA863955B (en) 1988-04-27
JPS6226234A (en) 1987-02-04
JPH0369332B2 (en) 1991-10-31
JPS6226233A (en) 1987-02-04
JPS6338327B2 (en) 1988-07-29
ZA863956B (en) 1988-04-27

Similar Documents

Publication Publication Date Title
GB2176703B (en) Novel formulation
GB8612780D0 (en) Formulation
AR242568A1 (en) Methylenedioxyphenanthrene
GB8513358D0 (en) Formulation
GB8529500D0 (en) Formulation
GB8524812D0 (en) Formulation
GB8500591D0 (en) Formulation
GB8521705D0 (en) Formulation
GB8521704D0 (en) Formulation
GB8506703D0 (en) Formulation
IL93223A0 (en) Formulations comprising 31-azido-31-deoxythymidine
GB8523690D0 (en) Formulations
GB8406326D0 (en) Formulation
GB8425313D0 (en) Formulation
AU91067S (en) Trestle
PL257276A1 (en) Trepanobiopsy set
CS122185A1 (en) Sposob znizenia zatazenia velkoplosnych kontaktnych pilierov v okoli vydobyteho priestoru v horskom masive
CS718985A1 (en) Zpusob stanoveni obsahu hydroxylovych skupin v rganickych latkach
CS127285A1 (en) Zapojeni automatickeho systemu vyhodnoceni zejmena teploty v dolech
CS1001085A1 (en) Zpusob zvyseni obsahu pryskyric v borovych stromech
CS172285A1 (en) Zapojeni bloku tvorby kmitoctu v zapisovaci
CS201885A1 (en) Dvojucelovy nosic injektaznich trysek v prestupnikovem kolenu koksovaci komory
CS214385A1 (en) Ulozeni membrany v elektromigracnim pristroji
CS238885A1 (en) Sposob urcenia najspolahlivejsej prenosovej cesty medzi dvojicou uzlov v telekomunikacnej sieti
CS379785A1 (en) Zpusob mereni vykonu elektromagnetickeho zareni absorbovaneho v ekeltricky ztratovych prostredich